JCAD | The Journal of Clinical and Aesthetic Dermatology (JCAD)

JCAD | The Journal of Clinical and Aesthetic Dermatology

   

JCAD » Questions-Challenges-Controversies

Subscribe in a reader

Archives

Sponsors

OBA

Supplements and Newsletters

Winter 2011 Newsletter: General Considerations and Management Principles in Atopic Dermatitis

Recent Posts

Recent Comments

<img src="http://www.jcadonline.com/ad-content/cloderm/banner_noflash.png" >

Questions • Challenges • Controversies: Use of Oral Isotretinoin in the Management of Rosacea

September 2011

Hyunhee Park, DO; James Q. Del Rosso, DO, FAOCD Read the rest of this article »

Posted in 09-2011 (September 2011), Questions-Challenges-Controversies | No Comments »

Chronic Administration of Oral Trimethoprim-Sulfamethoxazole for Acne Vulgaris

August 2011

Morgan McCarty, DO; James Q. Del Rosso, DO, FAOCD Read the rest of this article »

Posted in 08-2011 (August 2011), Questions-Challenges-Controversies | No Comments »

Repair and Maintenance of the Epidermal Barrier in Patients Diagnosed with Atopic Dermatitis: An Evaluation of the Components of a Body Wash-Moisturizer Skin Care Regimen Directed at Management of Atopic Skin

June 2011

James Q. Del Rosso, DO, FAOCD Read the rest of this article »

Posted in 06-2011 (June 2011), Questions-Challenges-Controversies | No Comments »

Status Report on the Management of Dermatofibrosarcoma Protuberans: Is There a Viable Role for the Use of Imatinib Mesylate? In Which Cases May It Be Therapeutically Helpful and in Which Cases Not?

March 2011

Grace K. Kim, DO; James Q. Del Rosso, DO, FAOCD

Dr. Kim is from Valley Hospital Medical Center, Las Vegas, Nevada. Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Dr. Kim reports no relevant conflicts of interest. Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott. Read the rest of this article »

Posted in 03-2011 (March 2011), Questions-Challenges-Controversies | No Comments »

The Emergence of Mycophenolate Mofetil in Dermatology

January 2011

The Emergence of Mycophenolate Mofetil in Dermatology: From Its Roots in the World of Organ Transplantation to its Versatile Role in the Dermatology Treatment Room

Hyunhee Park, DO; James Q. Del Rosso, DO, FAOCD Read the rest of this article »

Posted in 1-2011 (January 2011), Questions-Challenges-Controversies | No Comments »

An Evaluation of Evidence Regarding Application of Silicone Gel Sheeting for the Management of Hypertrophic Scars and Keloids

November 2010

Morgan McCarty, DO; James Q. Del Rosso, DO, FAOCD

Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Dr. McCarty is from Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Dr. Del Rosso is a consultant, speaker, and or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott. Dr. McCarty reports no relevant conflicts of interest. Read the rest of this article »

Posted in 11-2010 (November 2010), Questions-Challenges-Controversies | No Comments »

The Rationale Behind Topical Vitamin D Analogs in the Treatment of Psoriasis Where Does Topical Calcitriol Fit In?

August 2010

James Q. Del Rosso, DO, FAOCD; Grace K. Kim, DO

Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Dr. Kim is Dermatology Research Fellow, Mohave Skin & Cancer Clinics, Las Vegas, Nevada. Disclosure: Dr. Del Rosso is a consultant, speaker, and or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott. Dr. Kim reports no relevant conflicts of interest. Read the rest of this article »

Posted in 08-2010 (August 2010), Psoriasis, Questions-Challenges-Controversies | No Comments »

The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?

April 2010

Grace K. Kim, DO; James Q. Del Rosso, DO, FAOCD

Dr. Kim is Dermatology Research Fellow, Mohave Skin & Cancer Clinics, Las Vegas, Nevada. Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Drs. Kim and Del Rosso report no relevant conflicts of interest. Read the rest of this article »

Posted in 04-2010 (April 2010), Questions-Challenges-Controversies | No Comments »

Questions • Challenges • Controversies: How Clinically Relevant is Dapsone-related Peripheral Neuropathy? An Overview of Available Data with Emphasis on Clinical Recognition

March 2010

Morgan McCarty (MS4);
James Q. Del Rosso, DO, FAOCD

Section Editor: James Q. Del Rosso, DO, FAOCD

Ms. McCarty (MS4) is from Midwestern University AZCOM, Glendale, Arizona. Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Ms. McCarty and Dr. Del Rosso report no relevant conflicts of interest. Read the rest of this article »

Posted in 03-2010 (March 2010), Dapsone-related Peripheral Neuropathy, Questions-Challenges-Controversies | 1 Comment »

How Much Do We Really Know About Our Favorite Cosmeceutical Ingredients?

February 2010

Jacquelyn Levin, DO; James Q. Del Rosso, DO, FAOCD; Saira B. Momin, DO

Dr. Levin is from the Mohave Skin & Cancer Clinics, Dermatology Research Center, Las Vegas, Nevada; Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada; Dr. Momin is Chief Dermatology Resident (PGY-4), Valley Hospital Medical Center, Las Vegas, Nevada. Read the rest of this article »

Posted in 02-2010 (February 2010), Cosmeceuticals, Questions-Challenges-Controversies | No Comments »